These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31785807)

  • 1. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.
    Zhu W; Zhu Y; Xu H; Wang T; Wang J; Meng M; Liu Y; Yan H; Yang Q; Liu P
    Biochem Biophys Res Commun; 2020 Feb; 522(3):684-689. PubMed ID: 31785807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis.
    Wang Z; Hu Y; Xiao D; Wang J; Liu C; Xu Y; Shi X; Jiang P; Huang L; Li P; Liu H; Qing G
    Clin Cancer Res; 2017 Jul; 23(14):3834-3846. PubMed ID: 28143869
    [No Abstract]   [Full Text] [Related]  

  • 3. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.
    Robles-Valero J; Lorenzo-Martín LF; Menacho-Márquez M; Fernández-Pisonero I; Abad A; Camós M; Toribio ML; Espinosa L; Bigas A; Bustelo XR
    Cancer Cell; 2017 Nov; 32(5):608-623.e9. PubMed ID: 29136506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
    Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
    Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.
    Xi M; Guo S; Bayin C; Peng L; Chuffart F; Bourova-Flin E; Rousseaux S; Khochbin S; Mi JQ; Wang J
    Front Med; 2022 Jun; 16(3):442-458. PubMed ID: 34669156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
    Xu J; Peng J; Sun S; Wang D; Yuan W; Yang X; Shi T; Wang R; Liu H; Zhang P; Zhu HH
    Br J Haematol; 2024 Jun; 204(6):2301-2318. PubMed ID: 38685813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
    Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.
    Volanakis EJ; Williams RT; Sherr CJ
    Blood; 2009 Nov; 114(20):4451-9. PubMed ID: 19759355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro.
    Huang C; Hu X; Wang L; Lü S; Cheng H; Song X; Wang J; Yang J
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):801-9. PubMed ID: 22996635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin C is a haploinsufficient tumour suppressor.
    Li N; Fassl A; Chick J; Inuzuka H; Li X; Mansour MR; Liu L; Wang H; King B; Shaik S; Gutierrez A; Ordureau A; Otto T; Kreslavsky T; Baitsch L; Bury L; Meyer CA; Ke N; Mulry KA; Kluk MJ; Roy M; Kim S; Zhang X; Geng Y; Zagozdzon A; Jenkinson S; Gale RE; Linch DC; Zhao JJ; Mullighan CG; Harper JW; Aster JC; Aifantis I; von Boehmer H; Gygi SP; Wei W; Look AT; Sicinski P
    Nat Cell Biol; 2014 Nov; 16(11):1080-91. PubMed ID: 25344755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.
    Herranz D; Ambesi-Impiombato A; Sudderth J; Sánchez-Martín M; Belver L; Tosello V; Xu L; Wendorff AA; Castillo M; Haydu JE; Márquez J; Matés JM; Kung AL; Rayport S; Cordon-Cardo C; DeBerardinis RJ; Ferrando AA
    Nat Med; 2015 Oct; 21(10):1182-9. PubMed ID: 26390244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model.
    Zhang Y; Hua C; Cheng H; Wang W; Hao S; Xu J; Wang X; Gao Y; Zhu X; Cheng T; Yuan W
    Leuk Res; 2013 Nov; 37(11):1592-601. PubMed ID: 24090996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
    Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
    J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway.
    Liu Y; Fang B; Feng X; Jiang Y; Zeng Y; Jiang J
    Tissue Cell; 2022 Feb; 74():101674. PubMed ID: 34814054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.
    Zuo W; Huang F; Chiang YJ; Li M; Du J; Ding Y; Zhang T; Lee HW; Jeong LS; Chen Y; Deng H; Feng XH; Luo S; Gao C; Chen YG
    Mol Cell; 2013 Feb; 49(3):499-510. PubMed ID: 23290524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
    Zhang X; Geng L; Yang L; Wang Y; Zou Z; Zhang Y; Xu H; Lei H; Cao Y; Wu Y; Gu W; Zhou L
    Cell Signal; 2023 Oct; 110():110837. PubMed ID: 37544636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
    Sanchez-Martin M; Ferrando A
    Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
    Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
    Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
    Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
    Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.